ESPOSITO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.254
EU - Europa 6.514
AS - Asia 1.961
Continente sconosciuto - Info sul continente non disponibili 26
SA - Sud America 17
AF - Africa 16
OC - Oceania 7
Totale 18.795
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.207
GB - Regno Unito 2.393
IT - Italia 1.593
SE - Svezia 970
CN - Cina 676
SG - Singapore 578
DE - Germania 458
UA - Ucraina 405
TR - Turchia 371
FI - Finlandia 228
HK - Hong Kong 185
BG - Bulgaria 140
FR - Francia 113
IN - India 62
LT - Lituania 43
CA - Canada 42
RU - Federazione Russa 36
IR - Iran 35
IE - Irlanda 31
EU - Europa 24
BE - Belgio 23
NL - Olanda 23
CH - Svizzera 11
ES - Italia 10
KR - Corea 10
MY - Malesia 10
PK - Pakistan 9
ZA - Sudafrica 9
BR - Brasile 8
AU - Australia 7
ID - Indonesia 7
CO - Colombia 6
SI - Slovenia 6
CZ - Repubblica Ceca 4
JP - Giappone 4
PT - Portogallo 4
RS - Serbia 4
AT - Austria 3
GR - Grecia 3
PL - Polonia 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CL - Cile 2
CU - Cuba 2
DZ - Algeria 2
GE - Georgia 2
MG - Madagascar 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
ZW - Zimbabwe 2
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
BT - Bhutan 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
IM - Isola di Man 1
JO - Giordania 1
KW - Kuwait 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TH - Thailandia 1
Totale 18.795
Salva come PNG Salva come JPEG
Città #
Southend 2.066
Fairfield 1.105
Woodbridge 1.011
Chandler 918
Jacksonville 789
Ashburn 675
Houston 664
Santa Clara 654
Dearborn 572
Nyköping 514
Singapore 474
Wilmington 471
Ann Arbor 449
Cambridge 374
Seattle 373
Beijing 284
Izmir 245
Hong Kong 184
Princeton 147
Sofia 137
Eugene 135
San Diego 118
Milan 116
Modena 111
Des Moines 105
Rome 97
Helsinki 91
New York 82
Shanghai 59
Frankfurt am Main 55
Naples 46
London 39
Philadelphia 34
Bremen 33
Nanjing 33
Boardman 30
Bologna 29
Redwood City 29
Dublin 27
Florence 27
Verona 27
San Mateo 22
Hefei 21
Norwalk 21
Brussels 20
Palermo 20
Ottawa 19
Parma 19
Turin 19
Augusta 18
Falls Church 17
Kunming 17
Toronto 17
Catania 16
Guangzhou 16
Bari 15
Los Angeles 15
Brescia 14
Fremont 14
Grafing 14
Bangalore 12
Auburn Hills 11
Saint Petersburg 11
Bergamo 10
Indiana 10
Jinan 10
Mashhad 10
Monmouth Junction 10
Mumbai 10
Padova 10
Hounslow 9
Kilburn 9
Paris 9
San Jose 9
Ardabil 8
Cosenza 8
Pescara 8
Piacenza 8
Pisa 8
Treviso 8
Chiswick 7
Dallas 7
Jakarta 7
Leawood 7
Munich 7
Saint-martin-du-tertre 7
Amsterdam 6
Carpi 6
Kish 6
Napoli 6
Renton 6
Rio Saliceto 6
Sassari 6
Vicenza 6
Washington 6
Borås 5
Cagliari 5
East London 5
Genoa 5
Legnano 5
Totale 14.072
Salva come PNG Salva come JPEG
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.117
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease. 246
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 239
Gli ascessi epatici nei pazienti sottoposi a trapianto ortotopico di fegato 228
La clinica metabolica per il trattamento della lipodistrofia 211
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 209
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 206
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 205
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 200
Efficacy and safety of atazanavir in patients with end-stage liver disease. 200
Long-term psychometric outcomes of facial lipoatrophy therapy: forty-eight-week observational, nonrandomized study. 198
Brucellosis in a patient with end-stage liver disease undergoing liver transplantation: successful treatment with tigecycline. 191
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital 188
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 186
Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients 185
Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation. 185
Late presenters in an HIV surveillance system in Italy during the period 1992-2006. 185
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection. 185
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study. 182
Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases. 181
Differential Dose Adjustments of Immunosuppressants after Resuming Boosted versus Unboosted HIV-Protease Inhibitors Postliver Transplant. 181
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study 176
Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantation 176
Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR 175
Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1 174
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: An international observational study 174
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 173
Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naive HIV-positive patients. 172
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 171
Fatal cytomegalovirus necrotising enteritis in a small bowel transplantation adult recipient with low pp65 antigenaemia levels 170
Raltegravir and enfuvirtide as a “bridge” antiretroviral therapy in kidney-tranplanted patients with HIV infection receiving everolimus and low-dose cyclosporine: a case-control study 170
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 169
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 167
Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection 163
Applicazione della scala di valutazione, Functional indipendence Measure (FIM), per la valutazione dei programmi di riabilitazione per pazienti affetti da AIDS Dementia Complex ospiti di una casa alloggio 157
Artropodi vettori di agenti infettivi 157
Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy 157
Detectable HIV viral load is associated with metabolic syndrome. 155
Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients 155
Age-related comorbidities in people living with HIV 153
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease 150
Un caso di tubercolosi post-trapianto ortotopico di fegato: limiti dell’impiego del quantiferon-TB gold nella diagnosi della infezione tubercolare latente ed attiva 149
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 148
Rituximab as treatment of posttransplant lymphoproliferative disorder in patients who underwent small bowel/multivisceral transplantation: Report of three cases 147
Body image is a major determinant of sexual dysfunction in stable HIV-infected women. 145
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006). 145
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 144
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 144
Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function. 143
Outcome, incidence, and timing of infections in small bowel/multivisceral transplantation 139
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 137
Improving the appropriateness of antibiotic prescription in hospitals: a pilot study assessing the effectiveness of an infectious diseases specialist's consultation programme 136
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 135
Body Image is a major determinant of sexual dysfunction in stable HIV-infected women. 135
Severity of lipodystrophy is associated with decreased health-related quality of life 132
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 131
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 129
Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study 129
Pharmacokinetic interaction between amprenavir/ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation 128
Association of serum vitamin D levels nd type 2 diabetes in HIV infection in the Modena cohort 128
Immunophenotype of HIV plus patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system 128
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: The CARe study 127
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 127
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 126
Prevalence of secondary causes of osteoporosis among HIV infected individuals 126
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 124
CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 10(6) cells/I 124
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: The changes in opportunistic prophylaxis study 124
Alendronate for the treatment of Osteoporosis in HIV-infected patients. 124
Statistical agreement between ATPIII, IDF, EGIR, AACE metabolic syndrome classifications in HIV-infected patients and association with lipodystrophy 123
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 123
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 122
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 121
Bloodstream infections (BSIs) in Liver Transplant Recipients: Analisys at an Italian Tertiary-Care Hospital 121
Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count grater than 500 cells 119
Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of quantiferon TB GOLD results in the transplant setting: A case report 118
Assessment of 10-year probability of a major osteoporotic fracture in HIV-infected patients using FRAX® tool algorithms. 118
Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1 117
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 117
La trasmissione verticale di HIV nell’era della HAART 116
HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3. 116
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 116
Relapse of HIV-related buffalo hump after liposuction 116
Does lipodistrophy affect quality of life? 116
CD4-Guided treatment interruptions: a new possibile therapeutic strategy 113
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 112
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 111
Validity of body image perception in women with HIV. 110
Studio caso-controllo sui fattori di rischio delle infezioni micotiche nei pazienti sottoposti a trapianto ortotopico di fegato (OLT) da donatore cadavere e da donatore vivente. 110
È possibile un counselling HIV su internet? 110
Test di sensibilità antimicotica in vitro su isolati di Candida spp. da emocolture di pazienti ospedalizzati 108
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 108
GH response to GH-releasing hormone-arginine (GHRH+Arg) is impaired in women affected by human immunodeficiency virus (HIV)-related lipodystrophy 107
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 105
Statistical agreement between metabolic syndrome ATP-III, IDF, EGIR and ACE classification in HIV-infected patients and association with body fat redistribution 105
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 104
Declining morbidity and mortality in AIDS patients of an Italian nursing home 104
Body fat redistribution syndrome in HIV infected people is associated with good adherence to HAART 104
Body Image perception in HIV infected women with body fat redistribution. 103
Pathological fractures in patients with osteopenia and osteoporosis induced by antiretroviral therapy 103
Totale 15.672
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.484
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.764 0 0 0 0 367 521 577 511 313 95 193 187
2020/20212.617 236 78 182 255 404 230 213 288 133 280 195 123
2021/20222.286 31 374 189 246 53 85 118 177 220 134 367 292
2022/20232.854 300 261 229 240 316 467 46 288 333 55 166 153
2023/20241.739 111 139 122 176 283 151 149 199 52 60 104 193
2024/20251.553 219 94 93 387 760 0 0 0 0 0 0 0
Totale 19.000